Max Drol

$77.00

Manufacturer: Maxtreme
Substance: oxymetholone
Package: 10mg/tab. (100 tab.)

Category:

Description

General information on Oxydrol tablets in Italy

The only oral anabolic androgenic indicated in the treatment of anemia caused by deficient production of red blood cells. Androlic is contraindicated in: male patients with prostate or breast cancer, women with hypercalcaemia with breast cancer, women who are or may become pregnant, patients with nephrosis or the nephrotic stage of nephritis, patients with drug hypersensitivity or dysfunction. severe liver. Oxydrol 50 mg (Oxymetholone) British Dragon Presentation Tablets are green square tablets, with 50 printed on one side and BD separated by a score line, can be divided into 2 parts and sealed in 100 foil sachets.

Characteristics of Oxydrol tablets in Italy

Oxydrol BD is an oral drug in a dose of 50 mg per tablet. It is the strongest oral on the market. It has both androgenic and anabolic effects. Strength and weight gains are very important. It is very toxic to the liver. Oxydrol BD also aromatizes quite easily. Oxymetholone has been reported to produce gynecomastia users (probably not all around 50%). An anti-estrogen should be used to counteract aromatization. Nolvadex is a suggested anti-estrogen. Many side effects are associated including acne, hair loss, abdominal pain, headache, gynecomastia, high blood pressure and excessive water retention. Weight loss and strength usually occur after your period.

Buy Oxydrol tablets

Oxydrol BD also interrupts the natural production of testosterone. It is considered by the bodybuilding community to be the most effective oral steroid for building strength and size. However, Oxydrol BD has many side effects, making it relatively unsafe to use compared to other steroids.The average dose is 50 to 100 mg per day to 200 mg per day. Oxydrol BD is used in the bulking cycle with Sustanon and deca-durabolin.

Reviews

There are no reviews yet.

Be the first to review “Max Drol”

Your email address will not be published. Required fields are marked *